https://www.ajmc.com/view/dr-patrick-burnett-discusses-efficacy-safety-profile-of-roflumilast-cream-in-psoriasis
Patrick Burnett, MD, PhD, FAAD, chief medical officer of Arcutis Biotherapeutics, speaks on the positive safety and efficacy profile shown in the DERMIS-1 and DERMIS-2 trials exploring use of roflumilast cream in patients with chronic plaque psoriasis, includ…
Create an account or login to join the discussion